Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. - Wikidata - wikimedia - TriplyDB

Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.

Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.

http://www.wikidata.org/entity/Q38322174

about

Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice Epstein-Barr virus BamHi-a rightward transcript-encoded RPMS protein interacts with the CBF1-associated corepressor CIR to negatively regulate the activity of EBNA2 and NotchIC Hodgkin's disease and the Epstein-Barr virus.Epstein-Barr virus (EBV) nuclear antigen (EBNA)-4 mutation in EBV-associated malignancies in three different populations Epstein-Barr virus-associated lymphoid malignancies: the expanding spectrum of hematopoietic neoplasms PD-1/CTLA-4 Blockade Inhibits Epstein-Barr Virus-Induced Lymphoma Growth in a Cord Blood Humanized-Mouse Model Epigenetic Impact on EBV Associated B-Cell Lymphomagenesis Epstein-Barr virus nuclear antigen 1 does not cause lymphoma in C57BL/6J mice HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.TP53 gene mutations in Hodgkin lymphoma are infrequent and not associated with absence of Epstein-Barr virus.Epstein-Barr virus BMRF-2 and BDLF-3 expression in hairy leukoplakia.Newly emerging therapies targeting viral-related lymphomas.Reverse transcriptase (RT) inhibition of PCR at low concentrations of template and its implications for quantitative RT-PCR.The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines Epstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2A Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2.The Epstein-Barr virus and its association with human cancers.Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.The role of EBV in post-transplant malignancies: a review.Viral latency and its regulation: lessons from the gamma-herpesviruses.The expression and function of Epstein-Barr virus encoded latent genes Epstein-Barr virus and oncogenesis: from latent genes to tumours.LMP1-induced downregulation of CD99 molecules in Hodgkin and Reed-Sternberg cells.miRNAs in the pathogenesis of oncogenic human viruses.Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions.Unexpected patterns of Epstein-Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA.Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors.Short, discontinuous exposure to butyrate effectively sensitizes latently EBV-infected lymphoma cells to nucleoside analogue antiviral agents.Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders.Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68.Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus.Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors.A simple reverse transcriptase PCR assay to distinguish EBNA1 gene transcripts associated with type I and II latency from those arising during induction of the viral lytic cycle The Epstein-Barr virus EBNA-1 promoter Qp requires an initiator-like element.Localization of predisposition to Hodgkin disease in the HLA class II region.

P2860

Q24524255-0B7885F9-86E9-43B8-9410-56FC878ED1DD Q24530175-05AB94BD-ECAC-49AB-8908-FACFB07B193E Q24535291-BA137644-2B4E-4F69-A6E6-F2D158183047 Q24670596-D17587F0-C5F6-4270-8717-F96056D47EFD Q26824570-FB4DE29D-88D2-4071-82E8-C0688431E2D7 Q27313748-30FC962A-02AF-467F-AA5C-E0438A96B9B6 Q28068361-C2A330BD-928F-4E30-8626-05EFCE5A0EFA Q28594944-A34D7563-2D7B-42F1-A392-80C880A31E2A Q30452144-D2A84399-B38B-4CBF-9AAB-4BDC70DCBC83 Q30751714-EA6F6F8E-D332-4326-90CE-A25CFA96FA26 Q32128759-800C4B21-12FF-419C-88BA-5A850361EBB0 Q33699201-DED4761E-890B-4C2D-A0DE-525AC147253A Q33706250-FA59CE21-4BEF-4A34-BBB7-DACAD4D98F51 Q33783746-0937AE99-2382-415F-B9CB-CE42CB1F2043 Q33784685-0DC56092-4A85-4540-8E90-A3E99B7EDA89 Q33794029-F5C91187-8F50-429E-8A38-B5D289D5D0B4 Q33797347-3AFED0CE-28D4-4A6A-8FFA-0E03FF25B502 Q33882153-32EF427A-52AA-461D-A6FD-0A337CC847B4 Q33889168-7109FF62-965D-47BD-8A64-67B2D29D3A41 Q33925488-8D435B45-B2E7-4E4D-B1A9-D6C22F7B7B6E Q34039189-08BBC11D-CE77-4879-8E4B-2C5EA46F63B9 Q34089485-C2CEEC5D-7900-4ED1-BC26-3F2D13FDF631 Q34221194-BBAC25B0-6C66-4265-8C60-E4B1B1B68AEF Q34430225-FF5CF74B-35BA-47AF-92F5-28BBC7D37ED7 Q34504522-33A1FCDF-F4F5-4097-AD0D-517246272440 Q34576340-1516E04C-2976-40B5-B3FA-B0E20F59BF94 Q34703035-631129F9-618A-40BE-8B3E-A670DBBC83AD Q35127940-DA3F03AF-3BD7-4B4C-ABB0-4B0CCBB0D989 Q35414637-56B245BE-5FCC-4DCF-ACA1-CB3B3CFAC6A4 Q35690817-CE924917-3D3A-4C56-95EE-4FC34DC89F69 Q35733719-7F604E3F-6481-4DD0-8BDB-4C2A2AB41A3D Q35798521-3CCB2037-2CA2-445A-A399-C22FE70C7AC4 Q35833217-E1C25718-B7D7-4639-B36F-A626BF37562C Q35833821-72A3F83F-E9AC-4C9E-A11C-6076E0C09F4A Q35848189-3058A848-E8A2-4E26-845C-D47B5225A4D7 Q35854017-A6EBED41-A25D-4764-BBE6-1019DC96C403 Q35858022-2F785D28-E2D1-48F6-B931-BE32D0225EF8 Q35872919-7C175267-5543-43CE-9F0C-211C2A263EA9 Q35874869-87FDC0EB-C057-4467-ABC8-73E801827402 Q35888992-D536F5BB-ABCE-41D0-BA6B-DC319F16A079

P2860

Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.

http://www.wikidata.org/entity/Q38322174

description

1993 nî lūn-bûn

@nan

1993年の論文

@ja

1993年学术文章

@wuu

1993年学术文章

@zh-cn

1993年学术文章

@zh-hans

1993年学术文章

@zh-my

1993年学术文章

@zh-sg

1993年學術文章

@yue

1993年學術文章

@zh

1993年學術文章

@zh-hant

name

Epstein-Barr virus and Hodgkin ...... atency in the malignant cells.

@en

type

label

Epstein-Barr virus and Hodgkin ...... atency in the malignant cells.

@en

prefLabel

Epstein-Barr virus and Hodgkin ...... atency in the malignant cells.

@en

P1433

Q38322174-41498F09-02DB-44B3-AAF7-3434FABA9CD0

P1476

Q38322174-46374C3F-01ED-4480-91F8-A423381792A8

P2093

Q38322174-1AAEF13D-84D9-4803-8AD4-60327C1BAD20

Q38322174-1B0BD12A-6275-4027-B543-99778A9E6968

Q38322174-28F7E7BA-0453-446D-851F-0AB64E643A19

Q38322174-5BE2B3F0-3272-4114-A900-1E9A62599185

Q38322174-8A1A15D4-CE2F-4274-9C5E-BF20F45E25C2

Q38322174-A9A33D5C-CD33-47DF-9623-DEF16399272E

Q38322174-E78F7825-7318-43A9-AFDA-07043B27A05D

P2860

Q38322174-04ECEAA9-89BF-4064-B0D7-6C5E51768840

Q38322174-0501CBC9-46D0-49C3-BFAF-C2D30D7D6148

Q38322174-09174EF8-5F04-43A3-AC01-CC6849ECA4C5

Q38322174-0BF09F92-4822-4903-9695-DEAF8A003027

Q38322174-0EBE7749-581F-4EDD-ADFE-F1D5445A14C8

Q38322174-10AC22A2-026D-49AC-9743-7B8101948DD5

Q38322174-1905FE2F-F1CA-4835-81E5-372B6553B5A7

Q38322174-23753AA2-3815-42B6-998A-F65D8B60BBAF

Q38322174-3034489C-3688-428D-A203-78A818D17E6C

Q38322174-316D8C3C-50C3-40BA-B3C5-20AFEFFB0D0C

P304

Q38322174-1F5D3CE6-8CEB-4820-B236-174A46DED116

P31

Q38322174-6F147292-792C-4A18-AFE4-3BA6F39011DA

P356

Q38322174-10F0841B-B868-4417-987F-B04BDC67284C

P407

Q38322174-F7BD45A9-04AD-4E26-A87E-4B201E38971C

P433

Q38322174-B3AE905A-2E75-4E12-A009-81E2BE0D3D50

P478

Q38322174-6EEA2305-29F1-4CDB-9FEE-9A14883206EB

P577

Q38322174-1E2916FF-FC93-49B0-8277-19EAE2B98EF7

P698

Q38322174-E1BBA585-604F-42E6-BD0D-C7CC96B389DD

P921

Q38322174-188D528F-B9EB-43D1-ADE3-22BF8881CA4A

P932

Q38322174-ACCE0377-AAAC-498C-A09F-B123C9EBE2DC

P356

P1433

Journal of Experimental Medicine

P1476

Epstein-Barr virus and Hodgkin ...... atency in the malignant cells.

@en

P2093

Brooks L

http://www.w3.org/2001/XMLSchema#string

Crocker J

http://www.w3.org/2001/XMLSchema#string

Deacon EM

http://www.w3.org/2001/XMLSchema#string

Niedobitek G

http://www.w3.org/2001/XMLSchema#string

Pallesen G

http://www.w3.org/2001/XMLSchema#string

Rickinson AB

http://www.w3.org/2001/XMLSchema#string

Young LS

http://www.w3.org/2001/XMLSchema#string

P2860

EBV gene expression in an NPC-related tumour.

Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element.

Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells

Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma.

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

In vitro transcription of two Epstein-Barr virus specified small RNA molecules.

Presence of Epstein-Barr virus in Hodgkin's disease is not exclusive to Reed-Sternberg cells.

Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamHI-W probes in Hodgkin's disease

Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study

A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas.

P304

339-349

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.177.2.339

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

177

http://www.w3.org/2001/XMLSchema#string

P577

1993-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8381153

http://www.w3.org/2001/XMLSchema#string

P921

Epstein–Barr virus

P932

2190903

http://www.w3.org/2001/XMLSchema#string